Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PN8H
|
|||
| Former ID |
DNCL003489
|
|||
| Drug Name |
Pacritinib
|
|||
| Synonyms |
JAK inhibitor (alone or in combination)s
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Myelofibrosis [ICD-11: 2A20.2; ICD-10: D47.4] | Approved | [1] | |
| Company |
CTI Biopharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H32N4O3
|
|||
| Canonical SMILES |
C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2
|
|||
| InChI |
1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+
|
|||
| InChIKey |
HWXVIOGONBBTBY-ONEGZZNKSA-N
|
|||
| CAS Number |
CAS 937272-79-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 208712. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.